Voltar
Artigo Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Telemedicine and cancer research during the COVID‐19 pandemic

2020; Wiley; Volume: 123; Issue: 1 Linguagem: Inglês

10.1002/jso.26254

ISSN

1096-9098

Autores

Bruna Tirapelli Gonçalves, Glauco Baiocchi,

Tópico(s)

Cancer survivorship and care

Resumo

Journal of Surgical OncologyVolume 123, Issue 1 p. 359-360 LETTER TO THE EDITOR Telemedicine and cancer research during the COVID-19 pandemic Bruna Tirapelli Gonçalves RN, MSc, Bruna Tirapelli Gonçalves RN, MSc Department of Gynecologic Oncology, AC Camargo Cancer Center, São Paulo, BrazilSearch for more papers by this authorGlauco Baiocchi MD, PhD, Corresponding Author Glauco Baiocchi MD, PhD [email protected] orcid.org/0000-0002-8193-5582 Department of Gynecologic Oncology, AC Camargo Cancer Center, São Paulo, Brazil Correspondence Glauco Baiocchi, Departamento de Ginecologia Oncológica, AC Camargo Cancer Center, Rua Antonio Prudente, 211, São Paulo 01509-010, Brazil. Email: [email protected]Search for more papers by this author Bruna Tirapelli Gonçalves RN, MSc, Bruna Tirapelli Gonçalves RN, MSc Department of Gynecologic Oncology, AC Camargo Cancer Center, São Paulo, BrazilSearch for more papers by this authorGlauco Baiocchi MD, PhD, Corresponding Author Glauco Baiocchi MD, PhD [email protected] orcid.org/0000-0002-8193-5582 Department of Gynecologic Oncology, AC Camargo Cancer Center, São Paulo, Brazil Correspondence Glauco Baiocchi, Departamento de Ginecologia Oncológica, AC Camargo Cancer Center, Rua Antonio Prudente, 211, São Paulo 01509-010, Brazil. Email: [email protected]Search for more papers by this author First published: 13 October 2020 https://doi.org/10.1002/jso.26254Citations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookxLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Araujo DV, Watson GA, Siu LL. The day after COVID-19—Time to rethink oncology clinical research. JAMA Oncol. 2020. https://doi.org/10.1001/jamaoncol.2020.4240 PubMedGoogle Scholar 2 WHO Coronavirus Disease (COVID-19) Dashboard. Situation by country, territory or area. https://covid19.who.int. Accessed August 20, 2020. Google Scholar 3 Sentinel Node Mapping in High Risk Endometrial Cancer. ClinicalTrials.gov identifier: NCT 03366051. https://clinicaltrials.gov/ct2/show/NCT03366051?term=ALICE&recrs=ab&cond=Endometrial+Cancer&draw=2&rank=1. Accessed September 22, 2020. Google Scholar 4Cinar P, Kubal T, Freifeld A, et al. Safety at the time of the COVID-19 pandemic: how to keep our oncology patients and healthcare workers safe. J Natl Compr Cancer Netw. 2020; 18(5): 504-509. https://doi.org/10.6004/jnccn.2020.7572 CASWeb of Science®Google Scholar 5Frumovitz M, Obermair A, Coleman RL, et al. Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 2020; 21(6): 851-860. https://doi.org/10.1016/S1470-2045(20)30081-4 10.1016/S1470-2045(20)30081-4 PubMedWeb of Science®Google Scholar Citing Literature Volume123, Issue1January 2021Pages 359-360 ReferencesRelatedInformation

Referência(s)